ABSTRACT
OBJECTIVE: Nerve ultrasound (US) data on myelin protein zero (MPZ)-related Charcot-Marie-Tooth disease (CMT) are lacking. To offer a comprehensive perspective on MPZ-related CMTs, we combined nerve US with clinics, electrodiagnosis and histopathology. METHODS: We recruited 36 patients (12 MPZ mutations), and correlated nerve US to clinical, electrodiagnostic measures, and sural nerve biopsy. RESULTS: According to motor nerve conduction velocity (MNCV) criteria, nine patients were categorized as "demyelinating" CMT1B, 17 as "axonal" CMT2I/J, and 10 as dominant "intermediate" CMTDID. Sural nerve biopsy showed hypertrophic de-remyelinating neuropathy with numerous complex onion bulbs in one patient, de-remyelinating neuropathy with scanty/absent onion bulbs in three, axonal neuropathy in two, mixed demyelinating-axonal neuropathy in five. Electrodiagnosis significantly differed in CMT1B vs. CMT2I/J and CMTDID subgroups. CMT1B had slightly enlarged nerve cross sectional area (CSA) especially at proximal upper-limb (UL) sites. CSA was negatively correlated to UL MNCV and not increased at entrapment sites. Major sural nerve pathological patterns were uncorrelated to UL nerve US and MNCV. CONCLUSIONS: Sural nerve biopsy confirmed the wide pathological spectrum of MPZ-CMT. UL nerve US identified two major patterns corresponding to the CMT1B and CMT2I/J-CMTDID subgroups. SIGNIFICANCE: Nerve US phenotype of MPZ-CMT diverged from those in other demyelinating peripheral neuropathies and may have diagnostic value.
Subject(s)
Charcot-Marie-Tooth Disease/physiopathology , Myelin P0 Protein/deficiency , Adult , Aged , Charcot-Marie-Tooth Disease/diagnosis , Charcot-Marie-Tooth Disease/genetics , Electromyography , Female , Humans , Male , Middle Aged , Motor Neurons/physiology , Myelin P0 Protein/genetics , Myelin P0 Protein/metabolism , Sural Nerve/diagnostic imaging , Sural Nerve/metabolism , Sural Nerve/physiopathology , UltrasonographyABSTRACT
BACKGROUND: We could previously identify components of both the innate and the adaptive immune system as disease modifiers in the pathogenesis of models for Charcot-Marie-Tooth (CMT) neuropathies type 1B and 1X. As part of the adaptive immune system, here we investigated the role of antibodies in a model for CMT1B. METHODS: Antibodies were localized and characterized in peripheral nerves of the CMT1B model by immunohistochemistry and Western blot analysis. Experimental ablation of antibodies was performed by cross breeding the CMT1B models with mutants deficient in B-lymphocytes (JHD-/- mutants). Ameliorated demyelination by antibody deficiency was reverted by intravenous injection of mouse IgG fractions. Histopathological analysis was performed by immunocytochemistry and light and quantitative electron microscopy. RESULTS: We demonstrate that in peripheral nerves of a mouse model for CMT1B, endogenous antibodies strongly decorate endoneurial tubes of peripheral nerves. These antibodies comprise IgG and IgM subtypes and are preferentially, but not exclusively, associated with nerve fiber aspects nearby the nodes of Ranvier. In the absence of antibodies, the early demyelinating phenotype is substantially ameliorated. Reverting the neuropathy by reconstitution with murine IgG fractions identified accumulating antibodies as potentially pathogenic at this early stage of disease. CONCLUSIONS: Our study demonstrates that in a mouse model for CMT1B, endogenous antibodies contribute to early macrophage-mediated demyelination and disease progression. Thus, both the innate and adaptive immune system are mutually interconnected in a genetic model for demyelination. Since in Wallerian degeneration antibodies have also been shown to be involved in myelin phagocytosis, our study supports our view that inherited demyelination and Wallerian degeneration share common mechanisms, which are detrimental when activated under nonlesion conditions.
Subject(s)
Antibodies/metabolism , Charcot-Marie-Tooth Disease/complications , Demyelinating Diseases/etiology , Analysis of Variance , Animals , Antigens, Differentiation/metabolism , Charcot-Marie-Tooth Disease/genetics , Demyelinating Diseases/immunology , Disease Models, Animal , Female , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Macrophages/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myelin P0 Protein/deficiency , Myelin P0 Protein/genetics , Myelin P0 Protein/immunology , Sciatic Neuropathy/metabolism , Sciatic Neuropathy/pathology , Signal Transduction/immunologyABSTRACT
The relationship between dysmyelination and the progression of neuropathy in Charcot-Marie-Tooth (CMT) hereditary polyneuropathy is unclear. Mice heterozygously deficient for the myelin protein P0 gene (P0+/-) are indistinguishable from wild-type (WT) at birth and then develop a slowly progressing demyelinating neuropathy reminiscent of CMT Type 1b. Accumulating evidence suggests that impulse conduction can become lethal to acutely demyelinated central and peripheral axons. Here we investigated the vulnerability of motor axons to long-lasting, high-frequency repetitive stimulation (RS) in P0+/- mice as compared to WT littermates at 7, 12, and 20 months of age. RS was carried out in interrupted trains of 200 Hz trains for 3h. Tibial nerves were stimulated at the ankle while the evoked compound muscle action potentials (CMAPs) and the ascending compound nerve action potentials (CNAPs) were recorded from plantar muscles and the sciatic nerve, respectively. In 7-month old mice, there was recovery of CMAP and CNAP following RS. When mice were about one year old, electrophysiological recovery following RS was incomplete and in P0+/- also associated with morphological signs of partial Wallerian degeneration. The effect of RS was larger in P0+/- as compared to age-matched WT. When mice were about 2 years old, the effect was stronger and became similar between WT and P0+/-. RS was followed by a transient hyperpolarization, which decreased with age and was smaller in P0+/- than in WT. Our data suggest that both aging and the dysmyelinating disease process may contribute to the susceptibility to activity-induced axonal degeneration. It is possible that in aging mice and in P0+/- there is inadequate energy-dependent Na(+)/K(+) pumping, as indicated by the reduced post-stimulation hyperpolarization, which may lead to a lethal Na(+) overload in some axons.
Subject(s)
Axons/physiology , Charcot-Marie-Tooth Disease , Electric Stimulation/adverse effects , Myelin P0 Protein/deficiency , Action Potentials/genetics , Age Factors , Animals , Animals, Newborn , Biophysics , Charcot-Marie-Tooth Disease/genetics , Charcot-Marie-Tooth Disease/pathology , Charcot-Marie-Tooth Disease/physiopathology , Disease Models, Animal , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myelin P0 Protein/genetics , Neural Conduction/genetics , Sciatic Nerve/physiopathology , Statistics, Nonparametric , Time FactorsABSTRACT
Chronic inflammatory demyelinating polyneuropathy is a debilitating autoimmune disease characterized by peripheral nerve demyelination and dysfunction. How the autoimmune response is initiated, identity of provoking Ags, and pathogenic effector mechanisms are not well defined. The autoimmune regulator (Aire) plays a critical role in central tolerance by promoting thymic expression of self-Ags and deletion of self-reactive T cells. In this study, we used mice with hypomorphic Aire function and two patients with Aire mutations to define how Aire deficiency results in spontaneous autoimmune peripheral neuropathy. Autoimmunity against peripheral nerves in both mice and humans targets myelin protein zero, an Ag for which expression is Aire-regulated in the thymus. Consistent with a defect in thymic tolerance, CD4(+) T cells are sufficient to transfer disease in mice and produce IFN-γ in infiltrated peripheral nerves. Our findings suggest that defective Aire-mediated central tolerance to myelin protein zero initiates an autoimmune Th1 effector response toward peripheral nerves.
Subject(s)
Immune Tolerance , Myelin P0 Protein/deficiency , Point Mutation , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/immunology , Transcription Factors/deficiency , Transcription Factors/genetics , Amino Acid Sequence , Animals , Autoantibodies/blood , Disease Models, Animal , Female , Humans , Immune Tolerance/genetics , Mice , Mice, Inbred NOD , Mice, Mutant Strains , Mice, SCID , Molecular Sequence Data , Myelin P0 Protein/genetics , Myelin P0 Protein/physiology , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/blood , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/genetics , Transcription Factors/physiology , AIRE ProteinABSTRACT
Macrophages are critically involved in the pathogenesis of genetically caused demyelination, as it occurs in inherited demyelinating neuropathies. On the basis of the observation that upregulation of the Schwann cell-derived chemokine MCP-1 (CCL2) is a pathologically relevant mechanism for macrophage activation in mice heterozygously deficient for the myelin component P0 (P0+/-), we posed the question of the intracellular signaling cascade involved. By using western blot analysis of peripheral nerve lysates the MAP-kinases extracellular signal-regulated kinase 1/2 (ERK1/2) and MAP kinase/ERK kinase 1/2 (MEK1/2) showed an early and constantly increasing activation in P0 mutants. Furthermore, in nerve fibers from the P0+/- mutants, Schwann cell nuclei were much more often positive for phosphorylated ERK1/2 than in nerve fibers from wild type mice. In vitro experiments using the MEK1/2-inhibitor CI-1040 decreased ERK1/2-phosphorylation and MCP-1 expression in a Schwann cell-derived cell line. Finally, systemic application of CI-1040 lead to a decreased ERK1/2-phosphorylation and substantially reduced MCP-1-production in peripheral nerves of P0+/- mutant mice. Our study identifies MEK1/2-ERK1/2 signaling as an important intracellular pathway that connects the Schwann cell mutation with the activation of pathogenetically relevant macrophages in the peripheral nerves. These findings may have important implications for the treatment of inherited peripheral neuropathies in humans.
Subject(s)
Chemokine CCL2/metabolism , Extracellular Signal-Regulated MAP Kinases/physiology , Myelin P0 Protein/genetics , Schwann Cells/metabolism , Signal Transduction/physiology , Age Factors , Animals , Benzamides/pharmacology , Cell Line, Tumor , Cell Nucleolus/drug effects , Cell Nucleolus/metabolism , Enzyme Inhibitors/pharmacology , Enzyme-Linked Immunosorbent Assay/methods , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Myelin P0 Protein/deficiency , Nerve Growth Factors/metabolism , Neurilemmoma/pathology , Peripheral Nerves/cytology , S100 Calcium Binding Protein beta Subunit , S100 Proteins/metabolism , Schwann Cells/drug effects , Schwann Cells/ultrastructure , Signal Transduction/drug effects , TransfectionABSTRACT
Patients with hereditary neuropathies are more susceptible to vincristine (VIN)-induced neuropathy than patients without this comorbidity. The heterozygous P0(+/-) mouse is an animal model of a distinct form of inherited neuropathies. These mice produce only 50% of the major myelin protein protein zero (P0) and display signs of demyelination in motor nerves at 4 months of age. Here we investigated the development of neuropathic signs in P0(+/-) and wild-type (wt) mice after VIN treatment. Neuropathy was induced by daily intraperitoneal injections of VIN (0.5 mg/kg body weight) over 10 days. Behavioral and electrophysiological tests were performed at regular time points. Wt mice developed significant hypersensitivity to heat and mechanical stimuli between days 7 and 38 after the first VIN injection. Surprisingly, P0(+/-) mice did not show sensory or motor signs of neuropathy over the whole testing period. Immunohistochemical analysis showed an increase in macrophage numbers in sciatic nerve sections of wt mice after VIN, whereas P0(+/-) mice had higher baseline levels of macrophages without changes after VIN treatment. Semithin sections revealed a decrease in the number of small-diameter myelinated fibers in the sciatic nerves of wt mice after VIN application, whereas P0(+/-) mice had higher baseline values of this fiber subtype that did not change under treatment. Dorsal root ganglion neurons of both genotypes showed an up-regulation of voltage-gated sodium channel immunoreactivity after VIN application without differences between the genotypes. Thus, the P0(+/-) phenotype seems to be protected against VIN-induced neuropathy. The mechanism of this neuroprotection remains elusive.
Subject(s)
Antineoplastic Agents, Phytogenic/toxicity , Myelin P0 Protein/deficiency , Polyneuropathies/chemically induced , Vincristine/toxicity , Action Potentials/drug effects , Action Potentials/genetics , Animals , Behavior, Animal/drug effects , Electrophysiology/methods , Ganglia, Spinal/cytology , Gene Expression Regulation/drug effects , Hyperalgesia/genetics , Hyperalgesia/physiopathology , Immunohistochemistry/methods , Mice , Mice, Inbred C57BL , Mice, Knockout , NAV1.6 Voltage-Gated Sodium Channel , Nerve Tissue Proteins/metabolism , Neural Conduction/drug effects , Neural Conduction/genetics , Neurons/drug effects , Neurons/metabolism , Pain Measurement/methods , Polyneuropathies/pathology , Polyneuropathies/physiopathology , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Reaction Time/drug effects , Reaction Time/genetics , Sodium Channels/metabolism , Statistics, NonparametricABSTRACT
The myelin protein 0 (MPZ or P0) is a transmembrane glycoprotein that represents the most abundant myelin component. Mutations in the P0 gene are associated with one form of autosomal dominant demyelinating peripheral neuropathy, Charcot-Marie-Tooth disease type 1B (CMT1B). Because CMT1 may be associated with renal involvement, mostly focal segmental glomerulosclerosis, we hypothesized that P0 could be expressed in the kidney. P0 mRNA was detected by reverse transcriptase-PCR in the human and mouse renal cortex. P0 transcripts were identified by in situ hybridization at different stages of the mouse kidney development, especially in embryonic structures that give rise to the glomerulus. P0 protein was also detected by Western blot in human and rat glomerular extracts and in a human podocyte cell line using a monoclonal anti-P0 antibody. Immunofluorescence studies on human kidney sections showed that the podocytes were intensely labeled. Immunogold electron microscopy disclosed a predominant staining of the membranes of intracellular vesicles in podocytes. P0 was also detected in the podocyte cell membrane, including at the foot processes. P0(-/-) mice exhibited mild growth retardation and demyelinating neuropathy similar to the one observed in patients with CMT1B. They also presented mild albuminuria, without significant ultrastructural change of the glomerular basement membrane or the podocytes. These results demonstrate that P0, the major myelin protein, is also expressed during nephrogenesis and in mature kidney, mostly in podocytes. They suggest that P0 gene mutations might be involved in renal diseases.
Subject(s)
Kidney Glomerulus/physiology , Myelin P0 Protein/genetics , Podocytes/physiology , Urothelium/physiology , Adult , Animals , Base Sequence , DNA Primers , Humans , In Situ Hybridization , Kidney Cortex/physiology , Kidney Glomerulus/ultrastructure , Mice , Microscopy, Immunoelectron , Myelin P0 Protein/deficiency , Myelin P0 Protein/physiology , Rats , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
In mouse models of later onset forms of human hereditary demyelinating neuropathies, the immune system plays a crucial pathogenic role. Here, we investigated the influence of immune cells on early onset dysmyelination in mice homozygously deficient of the myelin component P0. In peripheral nerves of P0(-/-) mice, CD8+ T-lymphocytes increased with age. Macrophages peaked at 3 months followed by a substantial decline. They were mainly of hematogenous origin. To evaluate the functional role of immune cells, we cross-bred P0(-/-) mutants with RAG-1-deficient mice. At 3 months, the number of endoneurial macrophages did not differ from the macrophage number of immunocompetent myelin mutants, but the later decline of macrophages was not observed. Quantitative electron microscopy revealed that in plantar nerves of 6-month-old double mutants, significantly more axons had degenerated than in immunocompetent littermates. These data suggest a neuroprotective net effect of T-lymphocytes on axon survival in inherited, early onset dysmyelination.
Subject(s)
Demyelinating Diseases/immunology , Genes, RAG-1/genetics , Immune System/immunology , Peripheral Nervous System Diseases/immunology , Wallerian Degeneration/immunology , Age Factors , Animals , CD8-Positive T-Lymphocytes/immunology , Cell Proliferation , Cell Survival/genetics , Cell Survival/immunology , Chemotaxis, Leukocyte/genetics , Chemotaxis, Leukocyte/immunology , Demyelinating Diseases/genetics , Demyelinating Diseases/physiopathology , Disease Models, Animal , Macrophages/immunology , Mice , Mice, Knockout , Microscopy, Electron, Transmission , Myelin P0 Protein/deficiency , Myelin P0 Protein/genetics , Peripheral Nerves/metabolism , Peripheral Nerves/pathology , Peripheral Nerves/ultrastructure , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/physiopathology , Tibial Nerve/metabolism , Tibial Nerve/pathology , Tibial Nerve/ultrastructure , Wallerian Degeneration/genetics , Wallerian Degeneration/physiopathologyABSTRACT
The authors report in patients with Val102/fs null mutation a possibly age dependent variability of clinical and electrophysiologic phenotype, segmental conduction abnormalities mainly in ulnar nerves at the elbow, and excessive myelin foldings and thickenings. The authors hypothesize that myelin thickenings at the paranodal region, in concurrence with compression at usual entrapment sites or minor repetitive trauma, may induce segmental conduction abnormalities.
Subject(s)
Codon, Nonsense , Frameshift Mutation , Gait Disorders, Neurologic/genetics , Muscular Atrophy/genetics , Myelin P0 Protein/genetics , Myelin Sheath/pathology , Paresthesia/genetics , Reflex, Abnormal/genetics , Adult , Aged , Biopsy , Chromosomes, Human, Pair 17/genetics , Cumulative Trauma Disorders/complications , Female , Foot Deformities/genetics , Heterozygote , Humans , Male , Myelin P0 Protein/deficiency , Neural Conduction , Pedigree , Phenotype , Sural Nerve/pathology , Ulnar Nerve/physiopathologyABSTRACT
A Czech family with three individuals carrying a novel mutation, 290 A-->T (Glu97Val), in the myelin protein zero gene (P0) is reported. The two eldest carriers developed progressive sensorineural hearing loss and abnormal pupillary reaction at age 18. These preceded the onset of the classic signs of Charcot-Marie-Tooth disease (CMT) by more than a decade. Sural nerve biopsy and nerve conduction studies were compatible with the axonal type of CMT. The authors show that progressive hearing loss can be the first symptom in P0 mutation carriers.
Subject(s)
Charcot-Marie-Tooth Disease/genetics , Hearing Loss, Sensorineural/genetics , Mutation, Missense , Myelin P0 Protein/genetics , Point Mutation , Reflex, Pupillary/genetics , Adult , Age of Onset , Aged , Amino Acid Substitution , Biopsy , Charcot-Marie-Tooth Disease/epidemiology , Czechoslovakia , Disease Progression , Exons/genetics , False Negative Reactions , Female , Humans , Male , Myelin P0 Protein/deficiency , Neural Conduction , Pedigree , Phenotype , Reflex, Abnormal/genetics , Sural Nerve/pathologyABSTRACT
To elucidate the impact of myelinating Schwann cells on the molecular architecture of the node of Ranvier, we investigated the nodal expression of voltage-gated sodium channel (VGSC) isoforms and the localization of paranodal and juxtaparanodal membrane proteins in a severely affected Schwann cell mutant, the mouse deficient in myelin protein zero (P0). The abnormal myelin formation and compaction was associated with immature nodal cluster types of VGSC. Most strikingly, P0-deficient motor nerves displayed an ectopic nodal expression of the Na(v)1.8 isoform, where it is coexpressed with the ubiquitous Na(v)1.6 channel. Furthermore, Caspr was distributed asymmetrically or was even absent in the mutant nerve fibers. The potassium channel K(v)1.2 and Caspr2 were not confined to juxtaparanodes, but often protruding into the paranodes. Thus, deficiency of P0 leads to dysregulation of nodal VGSC isoforms and to altered localization of paranodal and juxtaparanodal components of the nodal complex.
Subject(s)
Gene Expression Regulation/genetics , Ion Channels/genetics , Ion Channels/metabolism , Myelin P0 Protein/deficiency , Nerve Fibers, Myelinated/metabolism , Potassium Channels, Voltage-Gated , Ranvier's Nodes/metabolism , Animals , Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/metabolism , Kv1.2 Potassium Channel , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Knockout , Mice, Neurologic Mutants , Myelin P0 Protein/genetics , Myelin Sheath/genetics , Myelin Sheath/metabolism , Myelin Sheath/pathology , Nerve Fibers, Myelinated/pathology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neural Conduction/genetics , Potassium Channels/genetics , Potassium Channels/metabolism , Protein Isoforms/genetics , Protein Isoforms/metabolism , Ranvier's Nodes/genetics , Ranvier's Nodes/pathology , Sodium Channel Blockers/pharmacologyABSTRACT
Genetic deficiency or instability of myelin protein zero (P0) results in hereditary motor sensory neuropathy. In view of recent advances in gene therapy, substitution of the molecular defect may become realistic in the near future. Here we investigate the impact of genetic deficiency of P0 on selection of the autoreactive T cell repertoire in the corresponding mouse model. We show that P0 mRNA transcripts are expressed in thymic stroma, similar to other myelin proteins and that expression of intact P0 protein can be detected by Western blot. Using a library of overlapping 20mer peptides spanning the entire length of P0 and applying the ELISPOT technique, we detected a strong immune response toward P0 extracellular domain peptide aa 41-60 in P0(-/-) knockout mice, but not in heterozygous P0(+/-) or wild-type (wt) mice. In addition, one cryptic epitope and two subdominant epitopes of P0 were identified. Using P0(-/-) into wt bone marrow (BM) chimeras we found that P0 expression in the host suffices for full tolerance induction, which is in line with its presence in thymic stroma. However, repopulation of P0(-/-) mice with wt BM led to partial induction of tolerance, suggesting that BM derived cells can also express this protein. Our findings may have implications for secondary autoimmunity developing after gene therapy in hereditary neuropathies and other diseases with genetically determined protein deficiency, because the repaired protein will then represent a foreign, nontolerized Ag.
Subject(s)
Immune Tolerance , Myelin P0 Protein/biosynthesis , Thymus Gland/immunology , Thymus Gland/metabolism , Amino Acid Sequence , Animals , Antigen Presentation/genetics , Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , Bone Marrow Cells/radiation effects , Cell Differentiation/genetics , Cell Differentiation/immunology , Epitopes, T-Lymphocyte/administration & dosage , Epitopes, T-Lymphocyte/analysis , Epitopes, T-Lymphocyte/metabolism , Fetus , Gene Dosage , Hematopoietic Stem Cells/immunology , Hematopoietic Stem Cells/metabolism , Hematopoietic Stem Cells/radiation effects , Immune Tolerance/genetics , Immunodominant Epitopes/administration & dosage , Immunodominant Epitopes/analysis , Immunodominant Epitopes/metabolism , Immunologic Memory/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Sequence Data , Myelin P0 Protein/deficiency , Myelin P0 Protein/immunology , Myelin P0 Protein/metabolism , Organ Culture Techniques , Peptide Fragments/administration & dosage , Peptide Fragments/immunology , Peptide Fragments/metabolism , Radiation Chimera/immunology , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Thymus Gland/cytologyABSTRACT
Previously, the authors have established spontaneously immortalized cell lines from long-term cultures of normal adult mouse Schwann cells. Establishment of such Schwann cell lines derived from murine disease models may greatly facilitate studies of the cellular mechanisms of their peripheral nervous system lesions in the relevant diseases. Recently, the authors have established immortalized Schwann cell lines derived from Niemann-Pick disease type C mice (NPC; spm/spm) and globoid cell leukodystrophy mice (twitcher). In the present study, long-term cultures were maintained of Schwann cells derived from dorsal root ganglia and consecutive peripheral nerves of another NPC mouse (npc(nih)/npc(nih), npc(nih)/+), myelin P0 protein-deficient mice (P0-/-, P0+/-) with their wild-type littermates (P0+/+), and neurofibromatosis type 1 gene (NF1)-deficient mice (Nf1(FCr)/+) for 8-10 months, and immortalized cell lines from all these animals established spontaneously. These cell lines had spindle-shaped Schwann cell morphology and distinct Schwann cell phenotypes and retained genomic and biochemical abnormalities, sufficiently representing the in vivo pathological features of the mutant mice. These immortalized Schwann cell lines can be useful in studies of nervous system lesions in these mutant mice and relevant human disorders.
Subject(s)
Cell Line, Transformed/cytology , Schwann Cells/cytology , Animals , Blotting, Western , Cell Culture Techniques/methods , Fluorescent Antibody Technique , Ganglia, Spinal/cytology , Mice , Mice, Neurologic Mutants , Microscopy, Electron , Myelin P0 Protein/deficiency , Neurofibromatosis 1/genetics , Niemann-Pick Diseases/genetics , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Mice deficient in the gap junction protein connexin 32 (Cx32) develop a slowly progressing demyelinating neuropathy, with enlarged periaxonal collars, abnormal non-compacted myelin domains and axonal sprouts. These mice serve as a model for the X-linked form of inherited demyelinating neuropathies in humans. Based on our previous findings that macrophages are involved in demyelination in other myelin mutants (i.e. mice heterozygously deficient in P0), we considered the possibility that macrophages might be also mediators of demyelination in Cx32-deficient mice. Indeed, we detected an age-related increase in the number of macrophages in demyelinating nerves of Cx32-deficient mice. In addition, immunoelectron microscopy revealed macrophages in an apposition to degenerating myelin reminiscent of a macrophage-mediated demyelinating neuropathy. We conclude that involvement of macrophages might be a widespread phenomenon in genetically-determined demyelination.
Subject(s)
Connexins/deficiency , Gap Junctions/genetics , Macrophages/metabolism , Peripheral Nerves/metabolism , Polyradiculoneuropathy/genetics , Animals , Antigens, Differentiation/metabolism , Axons/metabolism , Axons/pathology , Axons/ultrastructure , Cell Count , Connexins/genetics , Female , Gap Junctions/pathology , Gap Junctions/ultrastructure , Immunohistochemistry , Macrophages/pathology , Macrophages/ultrastructure , Male , Mice , Mice, Knockout , Microscopy, Electron , Myelin P0 Protein/deficiency , Myelin P0 Protein/genetics , Peripheral Nerves/pathology , Peripheral Nerves/ultrastructure , Polyradiculoneuropathy/immunology , Polyradiculoneuropathy/pathology , Schwann Cells/metabolism , Schwann Cells/pathology , Schwann Cells/ultrastructure , Up-Regulation/genetics , Up-Regulation/immunology , Gap Junction beta-1 ProteinABSTRACT
Mice heterozygously deficient in the major myelin component P0 are an established model of an inherited neuropathy and show signs of myelin degeneration in motor nerves. Unlike the case in patients, the sensory nerves are only mildly affected in the mouse mutants and do not show features indicative of myelin degeneration. Unexpectedly, by applying established behavioral tests, we found sensory deficits, as reflected by raised withdrawal thresholds to mechanical and thermal stimuli, whereas behavioral signs of a painful neuropathy were not detectable. By electron microscopy of longitudinal sections of sensory nerves, we found abnormalities in nodes of Ranvier comprising enlarged nodal gaps and poorly developed nodal Schwann cell microvilli. These alterations might be causally linked to the sensory deficits in the absence of profound myelin degeneration in the sensory nerves of the mutants.
Subject(s)
Myelin P0 Protein/deficiency , Myelin Sheath/pathology , Peripheral Nervous System Diseases/genetics , Ranvier's Nodes/pathology , Schwann Cells/pathology , Somatosensory Disorders/genetics , Wallerian Degeneration/genetics , Animals , Female , Genotype , Heterozygote , Hyperalgesia/genetics , Hyperalgesia/metabolism , Hyperalgesia/pathology , Male , Mice , Mice, Knockout , Microscopy, Electron , Movement Disorders/genetics , Movement Disorders/metabolism , Movement Disorders/pathology , Myelin P0 Protein/genetics , Myelin Sheath/metabolism , Myelin Sheath/ultrastructure , Nerve Crush , Neural Conduction/genetics , Pain Threshold/physiology , Peripheral Nervous System Diseases/metabolism , Peripheral Nervous System Diseases/pathology , Physical Stimulation , Ranvier's Nodes/metabolism , Ranvier's Nodes/ultrastructure , Schwann Cells/metabolism , Schwann Cells/ultrastructure , Sciatic Nerve/injuries , Sciatic Nerve/pathology , Sciatic Nerve/ultrastructure , Somatosensory Disorders/metabolism , Somatosensory Disorders/pathology , Wallerian Degeneration/metabolism , Wallerian Degeneration/pathologyABSTRACT
Protein Zero (P0), the major structural protein in the peripheral nervous system (PNS) myelin, acts as a homotypic adhesion molecule and is thought to mediate compaction of adjacent wraps of myelin membrane. E-Cadherin, a calcium-dependent adhesion molecule, is also expressed in myelinating Schwann cells in the PNS and is involved in forming adherens junctions between adjacent loops of membrane at the paranode. To determine the relationship, if any, between P0-mediated and cadherin-mediated adhesion during myelination, we investigated the expression of E-cadherin and its binding partner, beta-catenin, in sciatic nerve of mice lacking P0 (P0(-/-)). We find that in P0(-/-) peripheral myelin neither E-cadherin nor beta-catenin are localized to paranodes, but are instead found in small puncta throughout the Schwann cell. In addition, only occasional, often rudimentary, adherens junctions are formed. Analysis of E-cadherin and beta-catenin expression during nerve development demonstrates that E-cadherin and beta-catenin are localized to the paranodal region after the onset of myelin compaction. Interestingly, axoglial junction formation is normal in P0(-/-) nerve. Taken together, these data demonstrate that P0 is necessary for the formation of adherens junctions but not axoglial junctions in myelinating Schwann cells.
Subject(s)
Adherens Junctions/metabolism , Cadherins/metabolism , Cell Adhesion Molecules, Neuronal , Cytoskeletal Proteins/metabolism , Myelin P0 Protein/deficiency , Peripheral Nerves/growth & development , Peripheral Nerves/metabolism , Schwann Cells/metabolism , Trans-Activators , Adherens Junctions/ultrastructure , Aging/genetics , Animals , Axons/metabolism , Axons/ultrastructure , Cadherins/genetics , Cell Adhesion/genetics , Cell Communication/genetics , Cytoskeletal Proteins/genetics , Fluorescent Antibody Technique , Gene Expression Regulation, Developmental/physiology , Mice , Mice, Knockout , Microscopy, Electron , Myelin P0 Protein/genetics , Myelin Sheath/metabolism , Myelin Sheath/ultrastructure , Myelin-Associated Glycoprotein/metabolism , Nerve Crush , Peripheral Nerves/ultrastructure , RNA, Messenger/metabolism , Ranvier's Nodes/metabolism , Ranvier's Nodes/ultrastructure , Rats , Rats, Sprague-Dawley , Receptors, Cell Surface/metabolism , Schwann Cells/ultrastructure , Sciatic Nerve/growth & development , Sciatic Nerve/metabolism , Sciatic Nerve/ultrastructure , beta CateninABSTRACT
Inherited demyelinating neuropathies are chronically disabling human disorders caused by various genetic defects, including deletions, single site mutations, and duplications in the respective myelin genes. We have shown in a mouse model of one distinct hereditary demyelinating neuropathy (heterozygous P0-deficiency, P0+-) that an additional null mutation in the recombination activating gene-1 (RAG-1--) leads to a substantially milder disorder, indicating a disease modifying role of T-lymphocytes. In the present study, we addressed the role of lymphocytes in the mouse model by reconstituting bone marrow of P0+-/RAG-1-- mice with bone marrow from immunocompetent wild-type mice. We compared the pathology and nerve conduction in double mutant mice (P0+-/RAG-1-- on a C57BL/6 background) with that in double mutants after receiving a bone marrow transplant. We found that the milder demyelination seen in the lymphocyte-deficient P0+-/RAG-1-- mutants was reverted to the more severe pathology by reestablishing a competent immune system by bone marrow transfer. These data corroborate the concept that the immune system contributes substantially to the pathologic process in this mouse model and may open new avenues to ameliorate human hereditary neuropathies by exploiting immunosuppressive treatments.
Subject(s)
Bone Marrow Transplantation/adverse effects , Immune System/abnormalities , Mice, Neurologic Mutants/immunology , Mutation/physiology , Myelin Sheath/immunology , Polyradiculoneuropathy/immunology , Animals , Bone Marrow Transplantation/methods , Disease Models, Animal , Electric Stimulation , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Neurologic Mutants/genetics , Mice, Neurologic Mutants/metabolism , Microscopy, Electron , Myelin P0 Protein/deficiency , Myelin P0 Protein/genetics , Myelin Sheath/genetics , Myelin Sheath/metabolism , Neural Conduction/genetics , Neural Conduction/immunology , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/immunology , Peripheral Nervous System Diseases/pathology , Polyradiculoneuropathy/genetics , Polyradiculoneuropathy/therapy , Spinal Nerve Roots/immunology , Spinal Nerve Roots/pathology , Spinal Nerve Roots/ultrastructure , T-Lymphocytes/immunology , T-Lymphocytes/metabolismABSTRACT
Mice heterozygously deficient in the p0 gene (P0(+/-)) are animal models for some forms of inherited neuropathies. They display a progressive demyelinating phenotype in motor nerves, accompanied by mild infiltration of lymphocytes and increase in macrophages. We have shown previously that the T lymphocytes are instrumental in the demyelination process. This study addresses the functional role of the macrophage in this monogenic myelin disorder. In motor nerves of P0(+/)- mice, the number of macrophages in demyelinated peripheral nerves was increased by a factor of five when compared with motor nerves of wild-type mice. Immunoelectron microscopy, using a specific marker for mouse macrophages, displayed macrophages not only in the endoneurium of the myelin mutants, but also within endoneurial tubes, suggesting an active role in demyelination. To elucidate the roles of the macrophages, we crossbred the myelin mutants with a spontaneous mouse mutant deficient in macrophage colony-stimulating factor (M-CSF), hence displaying impaired macrophage activation. In the P0-deficient double mutants also deficient in M-CSF, the numbers of macrophages were not elevated in the demyelinating motor nerves and demyelination was less severe. These findings demonstrate an active role of macrophages during pathogenesis of inherited demyelination with putative impact on future treatment strategies.
Subject(s)
Demyelinating Diseases/physiopathology , Macrophages/physiology , Myelin P0 Protein/physiology , Myelin Sheath/physiology , Peripheral Nerves/physiology , Spinal Nerve Roots/physiology , T-Lymphocytes/physiology , Animals , Crosses, Genetic , Demyelinating Diseases/genetics , Demyelinating Diseases/immunology , Disease Models, Animal , Femoral Nerve/physiology , Femoral Nerve/ultrastructure , Heterozygote , Major Histocompatibility Complex , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Immunoelectron , Myelin P0 Protein/deficiency , Myelin P0 Protein/genetics , Myelin Sheath/ultrastructure , Peripheral Nerves/ultrastructure , Spinal Nerve Roots/ultrastructureABSTRACT
The purpose of this study was to further characterize neuromyotonia in mice with deletions and point mutations of myelin protein genes. Clinical observation showed irregular stretching of the hindlimbs, tremor and generalized myokymia in mice with targeted deletions of the genes encoding myelin protein zero (P0-/-) or peripheral myelin protein 22 (Pmp22-/-), and Trembler mice, which carry a point mutation of Pmp22. By electromyography (EMG), we found irregular high-frequency bursts of spontaneous motor unit activity and rhythmic doublet or multiplet discharges of motor units in these mouse models of human hereditary neuropathies. The EMG signs are typical for neuromyotonia and myokymia, respectively. The activity persisted after a proximal nerve section in many cases, localizing the generator to the peripheral nerve or the muscle. We now show that blocking neuromuscular transmission with suxamethonium abolished the spontaneous activity, ruling out a muscle origin. Phenytoin ameliorated the motor behavior. Taken together, our study shows that neuromyotonia develops in different mouse models of hereditary myelinopathies. This indicates that spontaneous motor unit activity may underlie neuromyotonia, which is occasionally observed in Charcot-Marie-Tooth disease. These animal models will be useful to study the pathogenesis of neuromyotonia.
Subject(s)
Hereditary Sensory and Motor Neuropathy/genetics , Isaacs Syndrome/genetics , Myelin P0 Protein/genetics , Myelin Proteins/genetics , Animals , Gene Deletion , Hereditary Sensory and Motor Neuropathy/drug therapy , Hereditary Sensory and Motor Neuropathy/physiopathology , Humans , Isaacs Syndrome/drug therapy , Isaacs Syndrome/physiopathology , Mice , Mice, Knockout , Mice, Neurologic Mutants , Motor Activity/drug effects , Myelin P0 Protein/deficiency , Myelin P0 Protein/physiology , Myelin Proteins/deficiency , Myelin Proteins/physiology , Phenytoin/therapeutic use , Point Mutation , Sciatic Nerve/physiopathologyABSTRACT
The adhesive cell surface molecule P(0) is the most abundant glycoprotein in peripheral nerve myelin and fulfills pivotal functions during myelin formation and maintenance. Mutations in the corresponding gene cause hereditary demyelinating neuropathies. In mice heterozygously deficient in P(0) (P(0)(+/-) mice), an established animal model for a subtype of hereditary neuropathies, T-lymphocytes are present in the demyelinating nerves. To monitor the possible involvement of the immune system in myelin pathology, we cross-bred P(0)(+/-) mice with null mutants for the recombination activating gene 1 (RAG-1) or with mice deficient in the T-cell receptor alpha-subunit. We found that in P(0)(+/-) mice myelin degeneration and impairment of nerve conduction properties is less severe when the immune system is deficient. Moreover, isolated T-lymphocytes from P(0)(+/-) mice show enhanced reactivity to myelin components of the peripheral nerve, such as P(0), P(2), and myelin basic protein. We hypothesize that autoreactive immune cells can significantly foster the demyelinating phenotype of mice with a primarily genetically based peripheral neuropathy.